Literature DB >> 21752615

Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT.

T-F Lee1, H-M Ting, P-J Chao, F-M Fang.   

Abstract

AIMS: To compare the performance of volumetric-modulated arc radiotherapy (VMAT) by dual arc with fixed beam intensity-modulated radiotherapies (IMRTs) and single arc VMAT on nasopharyngeal carcinomas (NPC).
MATERIALS AND METHODS: Twenty NPC cases were re-planned using the planning system of the Pinnacle(3®)SmartArc (SA) module to compare the performance of the following four techniques: seven-field (7F) and 18-field (18F) fixed beam IMRT, and single (SA(1)) and dual arc VMAT (SA(2)). The plan was delivered on an Elekta Synergy™ Linac equipped with an 80-leaf 1cm multileaf collimator. Three dose levels of planning target volumes (PTVs) with 70/59.4/54.0Gy in 33 fractions were prescribed and delivered as a simultaneous integrated boost. The conformity index and homogeneity index of the PTVs, the comprehensive quality index (CQI), the normal tissue complication probability for the organs at risk (OARs), and the planning time, delivery efficiency and accuracy were analysed.
RESULTS: A significantly inferior conformity index at the three dose levels of PTV and homogeneity index of PTV(70) were observed in SA(1) compared with the other techniques. Comparable conformity index and homogeneity index of the PTV were observed among 7F/18F IMRT and SA(2). Based on the CQI of the 11 OARs, the most efficient dose reduction was observed in 18F IMRT followed in order by SA(2), 7F IMRT and SA(1). The planning time was on average 13.2/24.9/40.1/42.8min for 7F/18F IMRT/SA(1)/SA(2), respectively. With regards to the delivery efficiency compared with 7F IMRT, a 51 and 41% reduction in delivery time was achieved by SA(1) and SA(2), respectively. All techniques presented a high quality assurance pass rate (>98%) of the Γ(3mm,3%) criterion.
CONCLUSION: In NPC cases, SA(2) gave superior results in terms of PTV coverage and OAR sparing compared with SA(1) and approached the performance achieved by 18F IMRT, but without sacrificing the delivery efficiency.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21752615     DOI: 10.1016/j.clon.2011.06.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  37 in total

1.  A dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction vs 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer.

Authors:  B Huang; Z Fang; Y Huang; P Lin; Z Chen
Journal:  Br J Radiol       Date:  2014-05-16       Impact factor: 3.039

2.  Dosimetric influence of photon beam energy and number of arcs on volumetric modulated arc therapy in carcinoma cervix: A planning study.

Authors:  Girigesh Yadav; Manindra Bhushan; Abhinav Dewan; Upasna Saxena; Lalit Kumar; Deepika Chauhan; Kothanda Raman; Swarupa Mitra; Mahammood Suhail
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-17

3.  Comparison of plan optimization for single and dual volumetric-modulated arc therapy versus intensity-modulated radiation therapy during post-mastectomy regional irradiation.

Authors:  Li-Rong Zhao; Yi-Bing Zhou; Jian-Guo Sun
Journal:  Oncol Lett       Date:  2016-03-23       Impact factor: 2.967

4.  Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT.

Authors:  Xiaofang Dai; Yingchao Zhao; Zhiwen Liang; Meera Dassarath; Lu Wang; Lihui Jin; Lili Chen; James Dong; Robert A Price; C-M Ma
Journal:  Phys Med       Date:  2014-10-03       Impact factor: 2.685

5.  A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer.

Authors:  Farshad Foroudi; Lesley Wilson; Mathias Bressel; Annette Haworth; Colin Hornby; Daniel Pham; Jim Cramb; Suki Gill; Keen Hun Tai; Tomas Kron
Journal:  Radiat Oncol       Date:  2012-07-23       Impact factor: 3.481

6.  Volumetric modulated arc therapy vs. c-IMRT for the treatment of upper thoracic esophageal cancer.

Authors:  Wu-Zhe Zhang; Tian-Tian Zhai; Jia-Yang Lu; Jian-Zhou Chen; Zhi-Jian Chen; De-Rui Li; Chuang-Zhen Chen
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.

Authors:  Tsair-Fwu Lee; Shyh-An Yeh; Pei-Ju Chao; Liyun Chang; Chien-Liang Chiu; Hui-Min Ting; Hung-Yu Wang; Yu-Jie Huang
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

8.  Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience.

Authors:  Stephen Wan Leung; Tsair-Fwu Lee
Journal:  Radiat Oncol       Date:  2013-05-01       Impact factor: 3.481

9.  Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hung-Yu Wang; Hsuan-Chih Hsu; PaoShu Chang; Wen-Cheng Chen
Journal:  BMC Cancer       Date:  2012-12-04       Impact factor: 4.430

10.  Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams.

Authors:  Mingzan Zhuang; Tuodan Zhang; Zhijian Chen; Zhixiong Lin; Derui Li; Xun Peng; Qingchun Qiu; Renhua Wu
Journal:  Radiat Oncol       Date:  2013-05-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.